These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sequential Treatment of Estrogen Deficient, Osteopenic Rats with Alendronate, Parathyroid Hormone (1-34), or Raloxifene Alters Cortical Bone Mineral and Matrix Composition. Taylor EA, Donnelly E, Yao X, Johnson ML, Amugongo SK, Kimmel DB, Lane NE. Calcif Tissue Int; 2020 Mar; 106(3):303-314. PubMed ID: 31784772 [Abstract] [Full Text] [Related]
6. Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol. Bitto A, Burnett BP, Polito F, Marini H, Levy RM, Armbruster MA, Minutoli L, Di Stefano V, Irrera N, Antoci S, Granese R, Squadrito F, Altavilla D. Br J Pharmacol; 2008 Nov; 155(6):896-905. PubMed ID: 18695641 [Abstract] [Full Text] [Related]
7. Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate. Yano T, Yamada M, Inoue D. Calcif Tissue Int; 2017 Jul; 101(1):102-110. PubMed ID: 28337514 [Abstract] [Full Text] [Related]
12. Combination treatment with a selective androgen receptor modulator q(SARM) and a bisphosphonate has additive effects in osteopenic female rats. Vajda EG, Hogue A, Griffiths KN, Chang WY, Burnett K, Chen Y, Marschke K, Mais DE, Pedram B, Shen Y, van Oeveren A, Zhi L, López FJ, Meglasson MD. J Bone Miner Res; 2009 Feb; 24(2):231-40. PubMed ID: 18847323 [Abstract] [Full Text] [Related]
13. Differing Effects of Parathyroid Hormone, Alendronate, and Odanacatib on Bone Formation and on the Mineralization Process in Intracortical and Endocortical Bone of Ovariectomized Rabbits. Vrahnas C, Buenzli PR, Pearson TA, Pennypacker BL, Tobin MJ, Bambery KR, Duong LT, Sims NA. Calcif Tissue Int; 2018 Dec; 103(6):625-637. PubMed ID: 30019315 [Abstract] [Full Text] [Related]
14. Effects of the selective estrogen receptor modulator ospemifene on bone in rats. Kangas L, Härkönen P, Väänänen K, Peng Z. Horm Metab Res; 2014 Jan; 46(1):27-35. PubMed ID: 24108389 [Abstract] [Full Text] [Related]
15. [Combination or sequential treatment using PTH and anti-resorption therapies]. Suzuki H, Takeuchi Y. Clin Calcium; 2012 Mar; 22(3):415-20. PubMed ID: 22370309 [Abstract] [Full Text] [Related]
16. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats. El-Shitany NA, Hegazy S, El-Desoky K. Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454 [Abstract] [Full Text] [Related]
17. Raloxifene but not alendronate can compensate the impaired osseointegration in osteoporotic rats. Faverani LP, Polo TOB, Ramalho-Ferreira G, Momesso GAC, Hassumi JS, Rossi AC, Freire AR, Prado FB, Luvizuto ER, Gruber R, Okamoto R. Clin Oral Investig; 2018 Jan; 22(1):255-265. PubMed ID: 28357643 [Abstract] [Full Text] [Related]
20. [Skeletal biomechanical properties improvement in ovariectomized osteoporotic rats of teriparatide was retarded by alendronate]. Li M, Jiao J, Meng XW, Zhou XY, Xing XP, Xia WB, Wang O, Jiang Y, Liu HC, Hu YY. Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):104-7. PubMed ID: 16624115 [Abstract] [Full Text] [Related] Page: [Next] [New Search]